Cardiac biomarkers and detection methods for myocardial infarction
Sang Young Kim1, Jin-Pyo Lee2, Woo-Ri Shin2
1Department of Food Science and Biotechnology, Shin Ansan University, 135 Sinansandaehak-Ro, Danwon-Gu, Ansan, 15435 Republic of Korea.
Insights
Diagnosing myocardial infarction (MI) requires multiple methods. This study introduces novel biomarker and electrocardiogram-based approaches for faster, more accurate MI detection, incorporating aptamer technology.
Area of Science:
- Cardiology
- Biomarker Discovery
- Medical Diagnostics
Background:
- Myocardial infarction (MI), a critical heart attack, results from interrupted blood flow and oxygen deprivation to the heart muscle.
- Global incidence of MI is rising, with emerging links to COVID-19.
- Early detection is crucial for effective myocardial infarction treatment.
Purpose of the Study:
- To develop novel diagnostic tools and techniques for myocardial infarction.
- To improve the speed and accuracy of myocardial infarction diagnosis.
- To explore the integration of aptamer technology for enhanced diagnostic capabilities.
Main Methods:
- Development of an algorithm-based diagnostic method using electrocardiogram (ECG) data.
- Creation of a diagnostic method focused on biomarker detection.
- Investigation of aptamer-based approaches for myocardial infarction diagnosis.
Main Results:
- An algorithm-based diagnostic method for myocardial infarction was successfully developed using ECG data.
- A new diagnostic method based on biomarker detection was established.
- The study explored the potential of aptamer technology in myocardial infarction diagnostics.
Conclusions:
- Diagnosing myocardial infarction accurately necessitates a combination of methods, as single factors are insufficient.
- Integrating novel materials like aptamers into diagnostic strategies is essential.
- The developed methods aim to provide quicker and more precise myocardial infarction diagnosis.
Background:
A significant heart attack known as a myocardial infarction (MI) occurs when the blood supply to the heart is suddenly interrupted, harming the heart muscles due to a lack of oxygen. The incidence of myocardial infarction is increasing worldwide. A relationship between COVID-19 and myocardial infarction due to the recent COVID-19 pandemic has also been revealed.
Objective:
We propose a biomarker and a method that can be used for the diagnosis of myocardial infarction, and an aptamer-based approach.
Results:
For the diagnosis of myocardial infarction, an algorithm-based diagnosis method was developed using electrocardiogram data. A diagnosis method through biomarker detection was then developed.
Conclusion:
Myocardial infarction is a disease that is difficult to diagnose based on the aspect of a single factor. For this reason, it is necessary to use a combination of various methods to diagnose myocardial infarction quickly and accurately. In addition, new materials such as aptamers must be grafted and integrated into new ways.
Purpose Of Review:
The incidence of myocardial infarction is increasing worldwide, and some studies are being conducted on the association between COVID-19 and myocardial infarction. The key to properly treating myocardial infarction is early detection, thus we aim to do this by offering both tools and techniques as well as the most recent diagnostic techniques.
Recent Findings:
Myocardial infarction is diagnosed using an electrocardiogram and echocardiogram, which utilize cardiac signals. It is required to identify biomarkers of myocardial infarction and use biomarker-based ELISA, SPR, gold nanoparticle, and aptamer technologies in order to correctly diagnose myocardial infarction.
More Related Videos
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:30Acute Coronary Syndrome I: Introduction